D81.0

Clinical Causes: Genetic mutations affecting the development of immune cells Inheritance patterns, typically autosomal recessive Mutations in the AK2 gene, which is crucial for cellular energy production in the bone marrow cells Failure in the maturation process of lymphocytes and myeloid cells, including neutrophils

Key Symptoms: Severe and recurrent bacterial, viral, and fungal infections early in life Failure to thrive — poor growth and weight gain Persistent diarrhea or gastrointestinal issues Swollen lymph nodes or spleen due to infection Signs of immune system failure, such as skin infections that are slow to heal Low levels of immune cells like lymphocytes and neutrophils Possible life-threatening infections without effective immune response

Diagnosis Path: Diagnosis of SCID with reticular dysgenesis involves a combination of laboratory tests and clinical assessments: - Blood tests to assess immune cell counts, including lymphocytes and neutrophils - Genetic testing to identify mutations in relevant genes like AK2 - Immunophenotyping to analyze the types and functions of immune cells - Bone marrow examination to evaluate stem cell development Early diagnosis is crucial for managing the disease effectively and improving outcomes.

Treatment Protocols: Treatment options for SCID with reticular dysgenesis focus on supporting the immune system and preventing infections: - Hematopoietic stem cell transplantation (bone marrow transplant) is often the definitive treatment to establish healthy immune function - Enzyme replacement therapies and supportive care to reduce infection risk - Antibiotics, antivirals, and antifungal medications to treat and prevent infections - Gene therapy research is ongoing as a potential future treatment - Regular monitoring and prompt treatment of infections are vital to manage the condition Due to the severity of SCID with reticular dysgenesis, specialized medical teams typically coordinate care for affected individuals.